| Literature DB >> 22943491 |
Jactty Chew1, Peter S Zilm, Janet M Fuss, Neville J Gully.
Abstract
BACKGROUND: The Gram negative anaerobe Fusobacterium nucleatum has been implicated in the aetiology of periodontal diseases. Although frequently isolated from healthy dental plaque, its numbers and proportion increase in plaque associated with disease. One of the significant physico-chemical changes in the diseased gingival sulcus is increased environmental pH. When grown under controlled conditions in our laboratory, F. nucleatum subspecies polymorphum formed mono-culture biofilms when cultured at pH 8.2. Biofilm formation is a survival strategy for bacteria, often associated with altered physiology and increased virulence. A proteomic approach was used to understand the phenotypic changes in F. nucleatum cells associated with alkaline induced biofilms. The proteomic based identification of significantly altered proteins was verified where possible using additional methods including quantitative real-time PCR (qRT-PCR), enzyme assay, acidic end-product analysis, intracellular polyglucose assay and Western blotting.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22943491 PMCID: PMC3478200 DOI: 10.1186/1471-2180-12-189
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Figure 1Representative 2DE gel images of planktonic (pH 7.4; a, c, e and g) and biofilm cells (pH 8.2; b, d, f and h). a - d cytoplasmic proteins; e - h cell envelope proteins. Proteins that were differentially produced are annotated. Refer to Table 1 for protein identification and abundance.
Significantly regulated protein expression in response to growth pH 8.2
| Cellular energy | | | | | | | | | | | | |
| 2-oxoglutarate pathway | NAD-specific glutamate dehydrogenase (EC 1.4.1.2) | 148324272 | 1750 | 5 | C | 29 | 18.5 | 3.9 | 4.8 | 0.01 | 46.6/6.1 | 48/6.2 |
| | | | | 6 | C | 52 | 18.8 | 6.0 | 3.1 | 0.01 | | 48/6.6 |
| | | | | 7^ | C | 10 | 1.6 | 7.5 | 0.2 | 0.02 | | 35/7.9 |
| | | | | 8^ | C | 31 | 5.9 | 49.3 | 0.1 | 0.01 | | 23/9.5 |
| | | | | 9^ | C | 32 | 2.7 | 16.6 | 0.2 | 0.01 | | 24/8.0 |
| | | | | 10^ | C | 30 | nd | 24.4 | - | 0.01 | | 28/9.0 |
| | Gluaconyl-CoA decarboxylase A subunit (EC 4.1.1.70) | 148322789 | 0224 | 11 | C | 40 | 2.5 | 1.1 | 2.3 | 0.02 | 64.1/5.1 | 62/5.3 |
| | | | | 12 | C | 34 | 1.7 | nd | + | 0.02 | | 62/5.4 |
| | Glutamate formiminotransferase (EC 2.1.2.5) | 148323936 | 1404 | 13 | C | 47 | 0.6 | 14.3 | 0.1 | 0.01 | 36.0/5.5 | 38/5.6 |
| Butanoate synthesis | Butanoate: acetoacetate CoA transferase α subunit (EC 2.8.3.9) | 148323516 | 0970 | 14^ | C | 36 | nd | 3.7 | - | 0.01 | 23.3/6.1 | 23/5.8 |
| | | | | 15^ | C | 50 | nd | 2.9 | - | 0.01 | | 23/6.1 |
| | Butyryl-CoA dehydrogenase (EC 1.3.99.2) | 148323999 | 1467 | 16^ | C | 31 | nd | 6.7 | - | 0.05 | 41.8/7.8 | 39/8.1 |
| Acetate synthesis | Phosphate acetyltransferase (EC 2.3.1.8) | 148323174 | 0618 | 17^ | C | 7 | 3.8 | nd | + | 0.05 | 36.0/7.6 | 39/7.6 |
| Pyruvate metabolism | D-lactate dehydrogenase (EC 1.1.1.28) | 148324271 | 1749 | 18 | C | 41 | 1.2 | nd | + | 0.05 | 37.8/6.1 | 36/6.1 |
| | Pyruvate synthase (EC 1.2.7.1) | 148324582 | 2072 | 19^ | C | 1 | nd | 1.3 | - | 0.05 | 132.1/6.7 | 58/7.7 |
| One carbon pool by folate | Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9) | 148323933 | 1401 | 31 | M | 28 | nd | 2.0 | - | 0.01 | 22.9/4.9 | 19/4.9 |
| | | | | 32 | M | 12 | nd | 3.3 | - | 0.01 | | 19/5.0 |
| Transport | | | | | | | | | | | | |
| Substrate transport | Di-peptide binding protein DppA | 148323000 | 0440 | 1 | C | 8 | 1.6 | nd | + | 0.02 | 56.9/5.3 | 55/4.6 |
| | | | | 2 | C | 6 | 5.9 | 0.7 | 8.6 | 0.02 | | 55/4.8 |
| | | | | 3 | C | 5 | 4.1 | nd | + | 0.02 | | 55/4.9 |
| | | | | 4 | C | 5 | 1.8 | nd | + | 0.02 | | 55/5.0 |
| | Dicarboxylate: Proton (H+) TRAP-T (tripartite ATP-independent periplasmic) family transporter binding protein | 148323082 | 0524 | 33 | M | 10 | 100.1 | 1.7 | 6 | 0.01 | 28.9/5.0 | 39/4.9 |
| | | | | 34 | M | 13 | 57.1 | 0.6 | 10 | 0.02 | | 39/5.0 |
| | RND (resistance-nodulation-cell division) superfamily antiporter | 148323066 | 0508 | 35 | M | 10 | 1.0 | 3.9 | 0.3 | 0.01 | 40.8/5.2 | 43/5.1 |
| | | | | 36 | | 7 | 1.3 | 3.2 | 0.4 | 0.05 | | 43/5.2 |
| | TTT (tripartite tricarboxylate transporter) family receptor protein | 148322550 | 2414 | 37 | M | 21 | 1.3 | 3.2 | 0.1 | 0.04 | 35.2/5.5 | 33/5.2 |
| | ABC (ATP binding cassette) superfamily transporter binding protein | 148322870 | 0306 | 38 | M | 24 | 1.1 | nd | - | 0.01 | 32.0/4.7 | 32/4.6 |
| | | | | 39 | M | 24 | 1.3 | nd | - | 0.01 | | 32/4.6 |
| Porin | OmpIP family outer membrane porin | 148322338 | 2196 | 40 | M | 8 | 10.6 | 27.9 | 0.4 | 0.02 | 78.1/8.8 | 75/8.8 |
| | Fusobacterial outer membrane protein A (FomA) | 148323518 | 0972 | 41 | M | 12 | 63.6 | 14.3 | 4.4 | 0.03 | 42.3/8.4 | 42/7.8 |
| | | | | 42 | M | 12 | 58.1 | 2.3 | 25.8 | 0.03 | | 42/8.1 |
| | | | | 43 | M | 14 | 18.3 | nd | + | 0.01 | | 42/8.6 |
| | | | | 44 | M | 5 | 23.3 | 1.6 | 7.7 | 0.01 | | 40/9.2 |
| Electron acceptor | Electron transfer flavoprotein subunit A | 148324001 | 1469 | 20 | C | 9 | 0.1 | 3.2 | 0.0 | 0.01 | 42.5/5.5 | 25/5.2 |
| | | | | 21 | C | 19 | nd | 1.1 | - | 0.01 | | 25/5.4 |
| | Electron transfer flavoprotein subunit B | 148324000 | 1468 | 45 | M | 15 | nd | 5.1 | - | 0.01 | 28.6/4.7 | 27/4.7 |
| | NADH dehydrogenase (ubiquinones), RnfG subunit | 148322329 | 2186 | 46 | M | 10 | 0.9 | nd | + | 0.05 | 19.0/4.6 | 18/4.6 |
| Stress response | | | | | | | | | | | | |
| Heat shock proteins (HSP) | 60 kDa chaperonin (GroEL) | 29839341 | 1329 | 22 | C | * | 0.9 | 0.3 | 3.2 | 0.05 | 57.5/5.0 | 57/4.7 |
| | | | | 23 | C | * | 3.9 | 0.8 | 4.9 | 0.01 | | 57/4.7 |
| | | | | 24 | C | * | 3.8 | nd | + | 0.05 | | 57/4.9 |
| | 70 kDa chaperone protein (DnaK) | 40643393 | 1258 | 25 | C | * | 0.7 | 3.2 | 0.2 | 0.01 | 65.3/5.0 | 65/4.7 |
| | | | | 26 | C | * | 0.2 | 2.5 | 0.1 | 0.05 | | 65/4.7 |
| | Peptidyl-prolyl cis-trans isomerase | 148322857 | 0293 | 27 | C | 55 | 0.8 | nd | + | 0.01 | 26.7/5.0 | 27/4.6 |
| DNA repair | Recombination protein RecA | 148324333 | 1811 | 28 | C | 59 | 3.4 | nd | + | 0.05 | 35.2/5.6 | 35/5.5 |
| Protein synthesis | | | | | | | | | | | | |
| Translation | Elongation factor EF-Ts | 148323585 | 1043 | 29 | C | * | 0.2 | 2.0 | 0.1 | 0.02 | 33.0/5.3 | 35/5.1 |
| | | | | 30 | C | * | 0.7 | 2.8 | 0.1 | 0.03 | | 35/5.3 |
| | | | | 54 | M | 29 | nd | 2.6 | - | | | 38/5.2 |
| | Elongation factor EF-Tu | 148322297 | 2153 | 47 | M | 9 | nd | 5.5 | - | 0.01 | 43.4/5.1 | 45/5.5 |
| | | | | 48 | M | 10 | nd | 6.2 | - | 0.01 | | 45/5.6 |
| | Ribosomal protein S2 | 148323584 | 1042 | 49 | M | 9 | nd | 3.0 | - | 0.01 | 27.9/5.3 | 30/5.5 |
| | | | | 50 | M | 13 | nd | 3.2 | - | 0.01 | | 29/5.7 |
| Hypothetical protein | Hypothetical protein FNP_1008 | 148323554 | 1008 | 51 | M | 6 | 20.0 | 6.6 | 3.0 | 0.01 | 45.5/4.9 | 45/4.9 |
| | Hypothetical protein FNP_0594 | 148323151 | 0594 | 52 | M | 12 | 0.8 | 2.9 | 0.3 | 0.04 | 9.9/4.7 | 11/5.2 |
| Hypothetical protein FNP_0283 | 148322501 | 0238 | 53 | M | 6 | 6.6 | 16.6 | 0.4 | 0.01 | 18.0/5.0 | 10/5.0 | |
All proteins were identified using MALDI MS/MS except those marked with ‘^’ were identified using LC-ESI MS/MS.
1Protein accession number on National Centre for Biotechnology Information (NCBI).
2Annotated gene ID on Oralgen Database (http://www.oralgen.lanl.gov/_index.html).
3Spot number as shown in Figure 1.
4Protein present in either cytoplasmic (C) or membrane (M) fraction.
5Percentage of sequenced peptides from MS/MS analysis found to match the identified protein.
6The average protein density of biofilm cells (pH 8.2) compared to planktonic cells (pH 7.4) on gel images determined by PD-Quest software V. 7.2.
7Mean ratio of biofilm cell protein quantity against planktonic cell protein quantity; calculation based on 3–5 replicate gels.
8p-value, Student t-test.
9Predicted molecular weight (MW) and isoelectric point (pI) of protein determined from Oralgen Databases.
10Observed MW and pI of protein determined from 2DE gels (Figure 1).
+Proteins that were only resolved in biofilm cells.
-Proteins that were only resolved in planktonic cells.
nd – not detected on 2DE gels.
Figure 2Representation of protein groups that were regulated at pH 8.2 compared to 7.4.
Glucose consumption and metabolic end-products produced bygrown at pH 8.2 and 7.4
| 7.4 ± 0.1 | 23.1 ± 2.1 | 2.39 ± 0.12 | 5.7 ± 0.5 | 92.4 ± 8.6 | 59.4 ± 6.5 | 63.0 ± 5.1 | 8.87 ± 0.40 |
| 8.2 ± 0.1 | 65.9 ± 7.2 | 7.62 ± 0.71 | 18.3 ± 1.9 | 131.2 ± 11.6 | 115.3 ± 12.7 | 99.6 ± 10.8 | 13.73 ± 1.25 |
1Glucose utilisation expressed as mmoles of glucose g-1 cell protein.
2Intracellular polyglucose expressed as μg glucose mg-1 cell protein.
3Acidic end-products expressed in mmol g-1 cell protein.
4NAD-specific glutamate dehydrogenase (GDH) activity measured in cells expressed as GDH unit mg-1 cell protein
Figure 3Pathways for glucose and histidine/glutamate catabolism in Significantly regulated enzymes detected in this study at pH 8.2 are indicated by the enzyme commission (E.C) numbers (Refer to Table 1). Bold arrows indicate increased enzyme levels while double-slash indicates decreased enzyme expression.
Figure 4The gene and protein expression of (a) , (b) and (c) determined using either qRT-PCR or Western blotting. Column charts represent qRT-PCR results while insets represent Western blotting results. a) Western blotting shows a 1.4 fold increase in GroEL protein abundance while qRT-PCR shows 3-fold decrease in groEL gene transcripts in biofilm cells planktonic cells. b) Western blotting analysis shows similar levels of RecA in both planktonic and biofilm cells while qRT-PCR shows nearly 2-fold decrease in recA gene expression in biofilm cells. c) qRT-PCR shows a 3-fold decrease in dnaK gene transcripts in biofilm cells compared to planktonic cells.